tiprankstipranks
Trending News
More News >
Indivior PLC (INDV)
NASDAQ:INDV

Compare Indivior (INDV) vs. Competitors

Compare
193 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Indivior
$34.74
$4.36B
34.56
185.68%
5 Buy
0 Hold
0 Sell
Strong Buy
Neurocrine
$137.96
$13.43B
32.95
-8.44%
15 Buy
3 Hold
0 Sell
Strong Buy
Supernus Pharmaceuticals
$48.94
$2.81B
-143.96
25.79%
5 Buy
1 Hold
0 Sell
Strong Buy
Teva Pharmaceutical
$33.07
$36.66B
27.15
78.37%
10 Buy
1 Hold
0 Sell
Strong Buy
Collegium Pharmaceutical
$44.82
$1.42B
28.23
39.88%
4 Buy
0 Hold
0 Sell
Strong Buy
Amneal Pharmaceuticals
$13.95
$4.39B
993.66
61.63%
3 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INDV
Indivior
34.71
22.81
191.68%
NBIX
Neurocrine
137.96
-13.86
-9.13%
SUPN
Supernus Pharmaceuticals
49.06
10.69
27.86%
TEVA
Teva Pharmaceutical
33.07
15.34
86.52%
COLL
Collegium Pharmaceutical
45.35
13.23
41.19%
AMRX
Amneal Pharmaceuticals
14.11
5.85
70.82%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts